What Medicare’s 2033 Part A Trust Fund Projection Means for You
The 2026 Medicare Trustees Report says Medicare Part A’s hospital trust fund could be depleted in 2033. Here’s what that does — and does not — mean for beneficiaries right now.
Medicare & CMS Updates
Medicare rules, CMS guidance, reimbursement, and benefit changes affecting patients and providers.
-
-
Who Qualifies for Medicare’s $50 GLP-1 Bridge Starting July 1, 2026?
CMS’s new Medicare GLP-1 Bridge starts July 1, 2026, but it is not broad new obesity-drug coverage for everyone. Here is who may qualify, which drugs and uses are included, and what the $50 monthly price does not count toward under Part D.
-
What the 2026 Medicare premiums and deductibles mean for beneficiaries
CMS released the 2026 Medicare premium and deductible amounts on Nov. 14, 2025, and the changes can affect what many beneficiaries pay this year. The biggest updates are in Original Medicare, but total costs can still differ by plan, especially in Medicare Advantage and Part D.
-
CMS tightens hospital price transparency rules for 2026
CMS began enforcing updated hospital price transparency requirements on April 1, 2026. The changes are meant to make hospital pricing files clearer and more useful, but they still do not guarantee an easy-to-understand final bill.
-
CMS pauses new hospice and home health enrollments: what it means
CMS has put a six-month nationwide pause on new Medicare enrollment for hospices and home health agencies. Existing providers can keep serving patients, and current Medicare coverage does not change, but families choosing a new agency may face tighter screening and fewer new entrants while CMS says it works to curb fraud.
-
CMS and FDA Launch RAPID Pathway for Breakthrough Devices
CMS and the FDA have created a new Medicare coverage pathway aimed at speeding access to certain breakthrough medical devices. The first practical effect is a faster route to a proposed Medicare coverage decision after FDA authorization, but many details still depend on implementation.
-
CMS’s April 2026 drug prior authorization proposal could speed reviews
CMS has proposed a rule that would extend electronic prior authorization to certain drugs covered under a medical benefit. It would not take effect right away, and most patients would not feel the change until at least 2027 if the rule is finalized.
-
Health Costs & Coverage | Healthcare Policy | Hospitals & Healthcare Systems | Medicare & CMS Updates
CMS Starts Enforcing New Hospital Price Transparency Rules: What Patients and Health Systems Should Know
CMS says it began enforcing updated hospital price transparency rules on April 1, 2026, but patients should still treat posted prices as a starting point.
-
Hearing Loss and Medicare in 2026: Why Hearing Aids Are Still Mostly Out of Pocket
Original Medicare can pay for some hearing tests in 2026, but hearing aids are still usually excluded. Here is what changed, what did not, and what to compare.
-
Gathered Healthcare Pricing Data | Health Costs & Coverage | Healthcare Price Contributed Data | Medicare & CMS Updates
CMS Starts Enforcing New Hospital Price Transparency Rules: What Patients May Notice Now
As of April 1, 2026, CMS is enforcing updated hospital price transparency rules. The files may be easier to compare, but they still are not your final bill.
-
Adults 75 and Older Need Only One RSV Shot for Now: What New 2026 Guidance Means
Current U.S. guidance says adults 75 and older who have never had an RSV shot should get one dose now, with no repeat dose advised at this time.
-
A New Study Suggests Medicare’s Insulin Cap Is Helping. Why Many Americans Still Pay More.
A new Medicare study suggests the $35 insulin cap is lowering patients’ costs. But supplies, other diabetes expenses, and gaps outside Medicare still matter.
-
Why a Proposed 2027 ACA Rule Could Keep Adult Dental Care Out of Marketplace Plans
A new CMS proposal could close a pathway for states to add adult dental benefits to ACA Marketplace plans in 2027, leaving many shoppers with separate coverage.
-
What Medicare’s obesity-drug coverage debate could mean for people with knee arthritis
A knee arthritis study points to real symptom relief with semaglutide, but Medicare access still depends on why it is prescribed and who qualifies.
-
What the federal nursing home staffing rule means for residents, families, and care access in 2026
As of April 2026, the federal nursing home staffing rule is no longer being phased in. Here’s what it would have required and what families should watch now.
-
What the CY 2026 Medicare physician fee schedule could mean for patient access, preventive care, and physician practices
Medicare’s 2026 physician payment rule may improve care coordination, telehealth, and home visits, but local staffing and practice finances still matter.
-
What the New CMS Prior-Authorization Reports Can and Cannot Tell Patients in 2026
Some plans now have to post 2025 prior-authorization data. Here is what patients and clinicians can learn from the new CMS reports, and what they cannot.
-
Minnesota’s Medicaid funding deferral: Why providers may feel the strain before patients do
Minnesota’s Medicaid funding deferral does not automatically end coverage. The closer short-term risk is provider payment strain, tighter oversight, and access friction.
-
Gathered Healthcare Pricing Data | Health Costs & Coverage | Hospitals & Healthcare Systems | Medicare & CMS Updates
Hospital Price Transparency Rules Got Stricter on April 1, 2026. What Patients Can Actually Check Before Scheduling Care
CMS began enforcing updated hospital price transparency requirements on April 1, 2026. Here’s what patients can actually compare before planned care, what changed in hospital price files, and why the posted number is still not a final bill.
-
Medicare Changed Payment for Diabetic Foot Ulcer Skin Substitutes in 2026. What Patients Should Know
Medicare changed how it pays for many skin substitute products used in diabetic foot ulcers in 2026, but it did not broadly stop covering care. Here’s what the change may mean for access, treatment conversations, and when to seek help.
-
Will Medicare make Ozempic and Rybelsus cheaper? What people with diabetes should know now
The short answer is not yet. Medicare has selected Ozempic, Rybelsus, and Wegovy for drug price negotiation, but the negotiated Medicare price is not scheduled to begin until January 1, 2027. Here is what changed in 2026, why the timeline is confusing, and why your own costs can still vary by plan.
-
Men Get Osteoporosis Too: When to Ask About a Bone Density Scan
Osteoporosis is often treated like a women’s issue, but men can develop it too and may be diagnosed only after a serious fracture. Here is who should ask about a DXA bone density scan, how national policy differs from specialty guidance, and what Medicare may or may not cover.
End of content
End of content
